 SAN DIEGO, April 29, 2021 GLOBE NEWSWIRE -- Kura Oncology, Inc. Nasdaq: KURA, a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that it will report first quarter 2021 financial results after the close of U.S. financial markets on Thursday, May 6, 2021. Kuras management will host a webcast and conference call at 4:30 p.m. ET 1:30 p.m. PT that day to discuss the financial results and provide a corporate update. 